Quote:
Originally Posted by Chris
Actually Jfman raised an interesting point the other day ... a useful side-effect of the decision not to use the Oxford vaccine on older people in many European countries has handed their governments a decent excuse to explain their limited supply and also to do what the statistics say you should, but human decency says you shouldn't, which is to give the vaccine to younger people, who have more life ahead of them, and leave the elderly to take their chances...
|
Well it allows them to take a differentiated approach to it by guaranteeing the elderly the more effective vaccines and the younger, who are less likely to develop complications in any case, can use the least effective of the approved vaccines.
It also applies the logic we did of using the 12 week window that it’s better to give more people some immunity than people than a small number of people strong immunity.
It’s very easy to spin given the immediate confusion in the AZ trial results.